Alzheimer’s patients’ cognition improves with Sargramostim (GM-CSF), new study shows
Higher health care costs linked with excess weight across range of BMIs
24 March 2021Suicide attempts spike soon after dementia diagnosis
24 March 2021Alzheimer’s patients’ cognition improves with Sargramostim (GM-CSF), new study shows
A new study suggests that Sargramostim, a medication often used to boost white blood cells after cancer treatments, is also effective in treating and improving memory in people with mild-to-moderate Alzheimer’s disease. This medication comprises of a natural human protein produced by recombinant DNA technology (yeast-derived rhu GM-CSF/Leukine).
